Bellicum Pharmaceuticals Earnings Surprises image   This BLCM earnings surprises page last updated 3/21/2023
Bellicum Pharmaceuticals Earnings Surprises Chart
PeriodExpectedActualSurprise
Q2 2021 -1.37 -0.22 +1.15 (-84%)
Q4 2020 -1.06 1.14 +2.20 (-208%)
Q4 2019 -4.00 -5.82 -1.82 (+46%)
Q3 2019 -5.30 -6.80 -1.50 (+28%)
Q2 2019 -5.40 -5.80 -0.40 (+7%)
Q1 2019 -5.80 -5.50 +0.30 (-5%)
Q4 2018 -5.60 -6.30 -0.70 (+12%)
Q3 2018 -5.80 -5.50 +0.30 (-5%)
Q2 2018 -5.50 -6.00 -0.50 (+9%)
Q1 2018 -6.90 -6.80 +0.10 (-1%)
Q3 2017 -7.40 -7.10 +0.30 (-4%)
Q1 2017 -7.00 -8.00 -1.00 (+14%)
Q4 2016 -7.00 -7.40 -0.40 (+6%)
Q3 2016 -6.20 -6.60 -0.40 (+6%)
Q2 2016 -5.70 -6.10 -0.40 (+7%)
Q1 2016 -5.10 -5.60 -0.50 (+10%)
Q2 2015 -4.90 -4.00 +0.90 (-18%)
Bellicum Pharmaceuticals Revenue Surprises Chart
PeriodExpectedActualSurprise
Q2 2021 250000 700000 +450000 (+180%)
Q4 2020 250000 500000 +250000 (+100%)
Q4 2019 630000 133000 -0.50M (-79%)
Q3 2019 1.20M 103000 -1.10M (+8583233%)
Q2 2019 870000 1.39M +521000 (-100%)
Q1 2019 650000 516000 -0.13M (-21%)
Q4 2018 1.19M 312000 -0.88M (+26218387%)
Q3 2018 110000 292000 +182000 (+165%)
Q2 2018 70000 362000 +292000 (+417%)
Q1 2018 30000 154000 +124000 (+413%)
Q3 2017 30000 126000 +96000 (+320%)
Q1 2017 70000 128000 +58000 (+83%)
Q4 2016 90000 81000 -9000 (-10%)
Q3 2016 70000 114000 +44000 (+63%)
Q2 2016 90000 101000 +11000 (+12%)
Q1 2016 250000 92000 -0.16M (-63%)
Q2 2015 230000 84000 -0.15M (-63%)
Quotes delayed 20 minutes

Email EnvelopeFree BLCM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options

Next Earnings Date Calendar:

Terran Orbital (LLAP): 3/21/2023 6:00 AM
X4 Pharmaceuticals (XFOR): 3/21/2023 6:00 AM
Biglari Holdings (BH): 3/21/2023 6:00 AM
Citi Trends (CTRN): 3/21/2023 6:45 AM
Resolute Forest Products (RFP): 3/21/2023 7:00 AM
Albireo Pharma (ALBO): 3/21/2023 8:00 AM
CinCor Pharma (CINC): 3/21/2023 8:00 AM
ProFrac Holding (ACDC): 3/21/2023 8:00 AM
MiNK Therapeutics (INKT): 3/21/2023 8:00 AM
Coupa Software (COUP): 3/21/2023 After close

More from the Next Earnings Dates Calendar

Earnings History:

Flotek Industries (FTK): 3/20/2023 After close
Ampco-Pittsburgh (AP): 3/20/2023 After close
Sanara MedTech (SMTI): 3/20/2023 After close
Exagen (XGN): 3/20/2023 After close
Graphite Bio (GRPH): 3/20/2023 After close
Canterbury Park Holding (CPHC): 3/20/2023 After close
Lantern Pharma (LTRN): 3/20/2023 After close
FAT Brands (FAT): 3/20/2023 After close
Radius Global Infr (RADI): 3/20/2023 After close
Movano (MOVE): 3/20/2023 8:30 AM

More from the Earnings History archive
Bellicum Pharmaceuticals (BLCM) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

BLFS Historical Earnings
BLI Historical Earnings
BLPH Historical Earnings
BLUE Historical Earnings
BMEA Historical Earnings
BMRA Historical Earnings
BMRN Historical Earnings
BMY Historical Earnings
BNGO Historical Earnings
BOLT Historical Earnings
On this page we presented the BLCM earnings surprises information for Bellicum Pharmaceuticals, comparing the expected earnings versus the actual earnings quarter by quarter, with the resulting positive or negative percentage surprise. Any self directed investor doing their due diligence on BLCM (or any other given stock) can benefit from researching all of the Bellicum Pharmaceuticals past earnings going backwards in time, including how often the company beat or missed the market's expectations. To help you with this Bellicum Pharmaceuticals earnings surprise research, on this page we presented each quarter's resulting numbers for easy comparison. Studying these numbers can help an investor by providing important context with which to think about BLCM's next earnings report. In your continued research on Bellicum Pharmaceuticals we hope you will be sure to check out the further links included for revenue and earnings history as well as next earnings dates for BLCM. Thanks for visiting, and the next time you need to research BLCM earnings surprises or those of another stock, we hope you'll think of our site as your go-to earnings surprises research resource of choice.

Recommended: Funds Holding JNUG, Top Ten Hedge Funds Holding BSE, CRSA YTD Return.

 

Bellicum Pharmaceuticals Earnings Surprises | www.NextEarningsDate.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in NextEarningsDate.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.